Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8643)
All Articles published online
|
Publishing Process of This Article
|
May 27, 2014 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wong RJ, Ahmed A. Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations. World J Hepatol 2014; 6(5): 263-273 [PMID: 24868320 DOI: 10.4254/wjh.v6.i5.263] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v6/i5/263.htm |
| Number | Citing Articles |
| 1 |
Mariana V. Machado, Sara Policarpo, J Coutinho, Sofia Carvalhana, Jorge Leitão, Armando Carvalho, Ana P. Silva, Francisco Velasco, Isabel Medeiros, Ana Catarina Alves, Mafalda Bourbon, Helena Cortez-Pinto. What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?. Obesity Surgery 2020; 30(2): 560 doi: 10.1007/s11695-019-04213-8
|
| 2 |
Pamela Valva, Daniela Rios, Paola Casciato, Adrián Gadano, Omar Galdame, Eduardo Mullen, Gustavo Bertot, Elena de Matteo, María V. Preciado. Nonalcoholic fatty liver disease: biomarkers as diagnostic tools for liver damage assessment in adult patients from Argentina. European Journal of Gastroenterology & Hepatology 2018; 30(6): 637 doi: 10.1097/MEG.0000000000001079
|
| 3 |
Shimin Wu, Hongjie Gao, Yumei Ma, Lina Fu, Cai Zhang, Xiaoping Luo. Characterisation of betatrophin concentrations in childhood and adolescent obesity and insulin resistance. Pediatric Diabetes 2016; 17(1): 53 doi: 10.1111/pedi.12233
|
| 4 |
Abhijit Chowdhury, Zobair M. Younossi. Alcoholic and Non-Alcoholic Fatty Liver Disease. 2016; : 21 doi: 10.1007/978-3-319-20538-0_2
|
| 5 |
Chandrajeet Yadav, Sandeep Dhruw, Pulkit Shekhawatia, Aman Gupta. SONOGRAPHICALLY DIAGNOSED NON-ALCOHOLIC FATTY LIVER AS A PREDICTOR OF METABOLIC SYNDROME. Journal of Evolution of Medical and Dental Sciences 2016; 5(15) doi: 10.14260/jemds/2016/166
|
| 6 |
Lin Liu, Hongmei Yan, MingFeng Xia, Lin Zhao, Minzhi Lv, Naiqin Zhao, Shengxiang Rao, Xiuzhong Yao, Weiyun Wu, Baishen Pan, Hua Bian, Xin Gao. Efficacy of exenatide and insulin glargine on nonalcoholic fatty liver disease in patients with type 2 diabetes. Diabetes/Metabolism Research and Reviews 2020; 36(5) doi: 10.1002/dmrr.3292
|
| 7 |
Daniel Ferraz de Campos Mazo, Rejane Mattar, José Tadeu Stefano, Joyce Matie Kinoshita da Silva-Etto, Márcio Augusto Diniz, Sebastião Mauro Bezerra Duarte, Fabíola Rabelo, Rodrigo Vieira Costa Lima, Priscila Brizolla de Campos, Flair José Carrilho, Claudia P Oliveira. Hypolactasia is associated with insulin resistance in nonalcoholic steatohepatitis. World Journal of Hepatology 2016; 8(24): 1019-1027 doi: 10.4254/wjh.v8.i24.1019
|
| 8 |
Warinda Susutlertpanya, Hirokazu Wakuda, Naoyuki Otani, Takuya Kuramoto, Li Li, Masae Kuranari, Ai Sekiguchi, Hideo Kudo, Tomohisa Uchida, Hiromitsu Imai, Naoto Uemura. Histological evaluation of nintedanib in non-alcoholic steatohepatitis mice. Life Sciences 2019; 228: 251 doi: 10.1016/j.lfs.2019.05.014
|
| 9 |
Dahn Jeong, Mohammad Ehsanul Karim, Stanley Wong, James Wilton, Zahid Ahmad Butt, Mawuena Binka, Prince Asumadu Adu, Sofia Bartlett, Margo Pearce, Emilia Clementi, Amanda Yu, Maria Alvarez, Hasina Samji, Héctor Alexander Velásquez García, Younathan Abdia, Mel Krajden, Naveed Zafar Janjua. Impact of HCV infection and ethnicity on incident type 2 diabetes: findings from a large population-based cohort in British Columbia. BMJ Open Diabetes Research & Care 2021; 9(1): e002145 doi: 10.1136/bmjdrc-2021-002145
|
| 10 |
Nima Motamed, Mahmoodreza Khoonsari, Mahshid Panahi, Nader Rezaie, Mansooreh Maadi, Fahimeh Safarnezhad Tameshkel, Hossein Keyvani, Mohammad Hadi Karbalaie Niya, Hossein Ajdarkosh, Seyyed Mohammad Miri, Farhad Zamani. The Incidence and Risk Factors of Non-Alcoholic Fatty Liver Disease: A Cohort Study from Iran. Hepatitis Monthly 2020; 20(2) doi: 10.5812/hepatmon.98531
|
| 11 |
Sanda Mustapic, Sead Ziga, Vladimir Matic, Tomislav Bokun, Bozo Radic, Marko Lucijanic, Srecko Marusic, Zarko Babic, Ivica Grgurevic. Ultrasound Grade of Liver Steatosis Is Independently Associated with the Risk of Metabolic Syndrome. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/8490242
|
| 12 |
P. Praveen Raj, Rachel M. Gomes, Saravana Kumar, Palanisamy Senthilnathan, Purushothaman Karthikeyan, Annapoorni Shankar, Chinnusamy Palanivelu. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: “NASHOST” prospective observational trial. Surgery for Obesity and Related Diseases 2015; 11(6): 1315 doi: 10.1016/j.soard.2015.02.006
|
| 13 |
Sara Ashtari, Mohamad Amin Pourhoseingholi, Mohamad Reza Zali. Non-alcohol fatty liver disease in Asia: Prevention and planning. World Journal of Hepatology 2015; 7(13): 1788-1796 doi: 10.4254/wjh.v7.i13.1788
|
| 14 |
Adam Schmitz, Paul Haste, Matthew S. Johnson. Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation Prior to Abdominal Operation: a Retrospective Analysis. Journal of Gastrointestinal Surgery 2020; 24(10): 2228 doi: 10.1007/s11605-019-04384-w
|
| 15 |
Sital Singh, Gabriela N. Kuftinec, Souvik Sarkar. Non-alcoholic Fatty Liver Disease in South Asians: A Review of the Literature. Journal of Clinical and Translational Hepatology 2017; (XX): 1 doi: 10.14218/JCTH.2016.00045
|
| 16 |
Doreen Liou, Kathleen D. Bauer, Emily Fowler. Dietary Acculturation of Obesity Risk Reduction Behaviors in Chinese Americans. Family and Consumer Sciences Research Journal 2018; 47(2): 130 doi: 10.1111/fcsr.12289
|
| 17 |
Asim Kichloo, Shantanu Solanki, Khwaja F Haq, Dushyant Dahiya, Beth Bailey, Dhanshree Solanki, Jagmeet Singh, Michael Albosta, Farah Wani, Michael Aljadah, Harshil Shah, Hafiz Khan, Syed-Mohammed Jafri. Association of non-alcoholic fatty liver disease with gallstone disease in the United States hospitalized patient population. World Journal of Gastrointestinal Pathophysiology 2021; 12(2): 14-24 doi: 10.4291/wjgp.v12.i2.14
|
| 18 |
Juan C Lopez-Delgado, Francisco Esteve, Casimiro Javierre, Josep L Ventura, Rafael Mañez, Elisabet Farrero, Herminia Torrado, David Rodríguez-Castro, Maria L Carrio. Influence of cirrhosis in cardiac surgery outcomes. World Journal of Hepatology 2015; 7(5): 753-760 doi: 10.4254/wjh.v7.i5.753
|
| 19 |
Yaxi Chen, Zac Varghese, Xiong Z. Ruan. The molecular pathogenic role of inflammatory stress in dysregulation of lipid homeostasis and hepatic steatosis. Genes & Diseases 2014; 1(1): 106 doi: 10.1016/j.gendis.2014.07.007
|
| 20 |
Rokaya Abd El-Aziz, Mervat Naguib, Laila A. Rashed. Spleen size in patients with metabolic syndrome and its relation to metabolic and inflammatory parameters. The Egyptian Journal of Internal Medicine 2018; 30(2): 78 doi: 10.4103/ejim.ejim_86_17
|
| 21 |
Jee-Fu Huang, Pei-Chien Tsai, Ming-Lun Yeh, Chung-Feng Huang, Ching-I. Huang, Meng-Hsuan Hsieh, Chia-Yen Dai, Jeng-Fu Yang, Shinn-Chern Chen, Ming-Lung Yu, Wan-Long Chuang, Wen-Yu Chang. Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis. Journal of the Formosan Medical Association 2020; 119(1): 89 doi: 10.1016/j.jfma.2019.03.014
|
| 22 |
Mi-Ok Sim, Hae-In Lee, Ju Ri Ham, Kwon-Il Seo, Mi-Kyung Lee. Long-term supplementation of esculetin ameliorates hepatosteatosis and insulin resistance partly by activating AdipoR2–AMPK pathway in diet-induced obese mice. Journal of Functional Foods 2015; 15: 160 doi: 10.1016/j.jff.2015.03.014
|
| 23 |
Seung Ku Lee, Dae Wui Yoon, Si Woo Lee, Jong Yeol Kim, Jin Kwan Kim, Chol Shin. Non-alcoholic fatty liver disease among sasang constitutional types: a population-based study in Korea. BMC Complementary and Alternative Medicine 2015; 15(1) doi: 10.1186/s12906-015-0925-8
|
| 24 |
Cosmas Rinaldi A. Lesmana, Maria S. Paramitha, Irsan Hasan. Comprehensive Gut Microbiota. 2022; : 475 doi: 10.1016/B978-0-12-819265-8.00079-6
|
| 25 |
Naoki Nakagawa. Fatty liver index has potential as a predictor of hypertension in the Japanese general population. Hypertension Research 2023; 46(4): 896 doi: 10.1038/s41440-023-01209-x
|
| 26 |
Jie Han, Yaping He, Hui Zhao, Xiaowei Xu. Hypoxia inducible factor‐1 promotes liver fibrosis in nonalcoholic fatty liver disease by activating PTEN/p65 signaling pathway. Journal of Cellular Biochemistry 2019; 120(9): 14735 doi: 10.1002/jcb.28734
|
| 27 |
Bi-Ling Yang, Wen-Chieh Wu, Kuan-Chieh Fang, Yuan-Chen Wang, Teh-Ia Huo, Yi-Hsiang Huang, Hwai-I Yang, Chien-Wei Su, Han-Chieh Lin, Fa-Yauh Lee, Jaw-Ching Wu, Shou-Dong Lee, Silvia C. Sookoian. External Validation of Fatty Liver Index for Identifying Ultrasonographic Fatty Liver in a Large-Scale Cross-Sectional Study in Taiwan. PLOS ONE 2015; 10(3): e0120443 doi: 10.1371/journal.pone.0120443
|
| 28 |
Anton Gillessen, Hartmut H.-J. Schmidt. Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review. Advances in Therapy 2020; 37(4): 1279 doi: 10.1007/s12325-020-01251-y
|
| 29 |
María del Carmen Baez, Mariana Tarán, Mónica Moya, María de la Paz Scribano Parada. Modulation of Oxidative Stress in Heart Disease. 2019; : 313 doi: 10.1007/978-981-13-8946-7_12
|
| 30 |
Mark Yu Zheng Wong, Jonathan Jiunn Liang Yap, Mark Chang Chuen Cheah, George Boon Bee Goh, Khung Keong Yeo. Non-alcoholic fatty liver disease is associated with subclinical coronary artery
disease in otherwise healthy individuals. Annals of the Academy of Medicine, Singapore 2021; 50(6): 500 doi: 10.47102/annals-acadmedsg.2020639
|
| 31 |
Amedeo Lonardo, Stefano Bellentani, Curtis K. Argo, Stefano Ballestri, Christopher D. Byrne, Stephen H. Caldwell, Helena Cortez-Pinto, Antonio Grieco, Mariana V. Machado, Luca Miele, Giovanni Targher. Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups. Digestive and Liver Disease 2015; 47(12): 997 doi: 10.1016/j.dld.2015.08.004
|
| 32 |
Elina Petäjä, Hannele Yki-Järvinen. Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD—A Systematic Review. International Journal of Molecular Sciences 2016; 17(5): 633 doi: 10.3390/ijms17050633
|
| 33 |
Yasuyuki Komiyama, Utaroh Motosugi, Shinya Maekawa, Leona Osawa, Natsuko Nakakuki, Hitomi Takada, Masaru Muraoka, Yuichiro Suzuki, Mitsuaki Sato, Shinichi Takano, Mitsuharu Fukasawa, Tatsuya Yamaguchi, Hiroshi Onishi, Meng Yin, Nobuyuki Enomoto. Early diagnosis of hepatic inflammation in Japanese nonalcoholic fatty liver disease patients using 3D MR elastography. Hepatology Research 2023; 53(3): 208 doi: 10.1111/hepr.13858
|
| 34 |
Song-Huy Nguyen-Dinh, Albert Do, Trang Ngoc Doan Pham, Doan Y Dao, Trinh Nhu Nguy, Moon S Chen Jr. High burden of hepatocellular carcinoma and viral hepatitis in Southern and Central Vietnam: Experience of a large tertiary referral center, 2010 to 2016. World Journal of Hepatology 2018; 10(1): 116-123 doi: 10.4254/wjh.v10.i1.116
|
| 35 |
Mark Yu Zheng Wong, Jonathan Jiunn Liang Yap, Rehena Sultana, Mark Cheah, George Boon Bee Goh, Khung Keong Yeo. Association between non-alcoholic fatty liver disease and subclinical atherosclerosis in Western and Asian cohorts: an updated meta-analysis. Open Heart 2021; 8(2): e001850 doi: 10.1136/openhrt-2021-001850
|
| 36 |
Wei-Dong Li, Kun-Fa Fu, Gui-Mei Li, Yan-Shu Lian, Ai-Min Ren, Yun-Jue Chen, Jin-Rong Xia. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus. World Journal of Gastroenterology 2015; 21(32): 9607-9613 doi: 10.3748/wjg.v21.i32.9607
|
| 37 |
Hirayuki Enomoto, Nobuhiro Aizawa, Hiroki Nishikawa, Naoto Ikeda, Yoshiyuki Sakai, Ryo Takata, Kunihiro Hasegawa, Chikage Nakano, Takashi Nishimura, Kazunori Yoh, Akio Ishii, Tomoyuki Takashima, Yoshinori Iwata, Hiroko Iijima, Shuhei Nishiguchi. Relationship Between Hepatic Steatosis and the Elevation of Aminotransferases in HBV-Infected Patients With HBe-Antigen Negativity and a Low Viral Load. Medicine 2016; 95(17): e3565 doi: 10.1097/MD.0000000000003565
|
| 38 |
Pushpjeet Kanwar, Kris V. Kowdley. The Metabolic Syndrome and Its Influence on Nonalcoholic Steatohepatitis. Clinics in Liver Disease 2016; 20(2): 225 doi: 10.1016/j.cld.2015.10.002
|
| 39 |
Lijing Zhang, Bin Yang, Baoping Yu. Paeoniflorin Protects against Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice. Biological & Pharmaceutical Bulletin 2015; 38(7): 1005 doi: 10.1248/bpb.b14-00892
|
| 40 |
Andrea Garatti, Andrea Daprati, Marzia Cottini, Claudio F. Russo, Margherita Dalla Tomba, Giovanni Troise, Antonio Salsano, Francesco Santini, Roberto Scrofani, Francesca Nicolò, Elisa Mikus, Alberto Albertini, Luca Di Marco, Davide Pacini, Marco Picichè, Loris Salvador, Guglielmo M. Actis Dato, Paolo Centofanti, Domenico Paparella, Giorgios Kounakis, Alessandro Parolari, Lorenzo Menicanti. Cardiac Surgery in Patients With Liver Cirrhosis (CASTER) Study: Early and Long-Term Outcomes. The Annals of Thoracic Surgery 2021; 111(4): 1242 doi: 10.1016/j.athoracsur.2020.06.110
|
| 41 |
Myoung-Sun Lee, Joo-Seok Kim, Sun-Mi Cho, Seon Ok Lee, Sung-Hoon Kim, Hyo-Jeong Lee. Fermented Rhus verniciflua Stokes Extract Exerts an Antihepatic Lipogenic Effect in Oleic-Acid-Induced HepG2 Cells via Upregulation of AMP-Activated Protein Kinase. Journal of Agricultural and Food Chemistry 2015; 63(32): 7270 doi: 10.1021/acs.jafc.5b01954
|
| 42 |
Aneesah McClinton, Joy Gullo, Paulo N. Martins, Oscar K. Serrano. Access to liver transplantation for minority populations in the United States. Current Opinion in Organ Transplantation 2021; 26(5): 508 doi: 10.1097/MOT.0000000000000904
|
| 43 |
Ta-Ya Lin, Ming-Lun Yeh, Chung-Feng Huang, Ching-I Huang, Chia-Yen Dai, Meng-Hsuan Hsieh, Shinn-Chern Chen, Jee-Fu Huang, Ming-Lung Yu, Wan-Long Chuang. Disease progression of nonalcoholic steatohepatitis in Taiwanese patients: a longitudinal study of paired liver biopsies. European Journal of Gastroenterology & Hepatology 2019; 31(2): 224 doi: 10.1097/MEG.0000000000001285
|
| 44 |
Mayuko Ichimura-Shimizu, Yosuke Tsuchiyama, Yuki Morimoto, Minoru Matsumoto, Tomoko Kobayashi, Satoshi Sumida, Takumi Kakimoto, Takeshi Oya, Hirohisa Ogawa, Michiko Yamashita, Satoru Matsuda, Katsuhisa Omagari, Shu Taira, Koichi Tsuneyama. A Novel Mouse Model of Nonalcoholic Steatohepatitis Suggests that Liver Fibrosis Initiates around Lipid-Laden Macrophages. The American Journal of Pathology 2022; 192(1): 31 doi: 10.1016/j.ajpath.2021.10.002
|
| 45 |
Atikarn Janthongkaw, Sirinthip Klaophimai, Tanaporn Khampaya, Supaporn Yimthiang, Yilin Yang, Ruixue Ma, Apirak Bumyut, Phisit Pouyfung, Erman Salih Istifli. Effect of Green and Red Thai Kratom (Mitragyna speciosa) on pancreatic digestive enzymes (alpha-glucosidase and lipase) and acetyl-carboxylase 1 activity: A possible therapeutic target for obesity prevention. PLOS ONE 2023; 18(9): e0291738 doi: 10.1371/journal.pone.0291738
|
| 46 |
Llilian Arzola-Martínez, Keerthikka Ravi, Gary B. Huffnagle, Nicholas W. Lukacs, Wendy Fonseca. Lactobacillus johnsonii and host communication: insight into modulatory mechanisms during health and disease. Frontiers in Microbiomes 2024; 2 doi: 10.3389/frmbi.2023.1345330
|
| 47 |
S. Lallukka, H. Yki-Järvinen. Non-alcoholic fatty liver disease and risk of type 2 diabetes. Best Practice & Research Clinical Endocrinology & Metabolism 2016; 30(3): 385 doi: 10.1016/j.beem.2016.06.006
|
| 48 |
Anna Janina Engstler, Cathrin Sellmann, Cheng Jun Jin, Annette Brandt, Kathleen Herz, Josephine Priebs, Ina Bergheim. Treatment with alpha‐galactosylceramide protects mice from early onset of nonalcoholic steatohepatitis: Role of intestinal barrier function. Molecular Nutrition & Food Research 2017; 61(5) doi: 10.1002/mnfr.201600985
|
| 49 |
Christopher R. Shepard. TLR9 in MAFLD and NASH: At the Intersection of Inflammation and Metabolism. Frontiers in Endocrinology 2021; 11 doi: 10.3389/fendo.2020.613639
|
| 50 |
Yasir J. Abozaid, Ibrahim Ayada, Laurens A. van Kleef, Costanza L. Vallerga, Qiuwei Pan, Willem P. Brouwer, M. Arfan Ikram, Joyce Van Meurs, Robert J. de Knegt, Mohsen Ghanbari. Plasma proteomic signature of fatty liver disease: The Rotterdam Study. Hepatology 2023; 78(1): 284 doi: 10.1097/HEP.0000000000000300
|
| 51 |
Maximilian Wetterkamp, Cornelius J. van Beekum, Maria A. Willis, Tim R. Glowka, Steffen Manekeller, Rolf Fimmers, Michael Praktiknjo, Johannes Chang, Joerg C. Kalff, Tim O. Vilz. Risk Factors for Postoperative Morbidity and Mortality after Small Bowel Surgery in Patients with Cirrhotic Liver Disease—A Retrospective Analysis of 76 Cases in a Tertiary Center. Biology 2020; 9(11): 349 doi: 10.3390/biology9110349
|
| 52 |
Akshay Shetty, Jennifer W. Hsu, Paul P. Manka, Wing-Kin Syn. Role of the Circadian Clock in the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences 2018; 63(12): 3187 doi: 10.1007/s10620-018-5242-x
|
| 53 |
Aline Gottlieb, Anna-Sophia Leven, Jan-Peter Sowa, Katrin Borucki, Alexander Link, Elvan Yilmaz, Sitke Aygen, Ali Canbay, Mustafa Porsch-Özcürümez. Lipoprotein and Metabolic Profiles Indicate Similar Cardiovascular Risk of Liver Steatosis and NASH. Digestion 2021; 102(5): 671 doi: 10.1159/000510600
|
| 54 |
Binxia Chang, Baosen Li, Ang Huang, Ying Sun, Guangju Teng, Xiaoxia Wang, Suthat Liangpunsakul, Jin Li, Zhengsheng Zou. Changes of four common non-infectious liver diseases for the hospitalized patients in Beijing 302 hospital from 2002 to 2013. Alcohol 2016; 54: 61 doi: 10.1016/j.alcohol.2016.07.001
|
| 55 |
George B.B. Goh, Clarence Kwan, Sze Ying Lim, Nanda KK Venkatanarasimha, Rafidah Abu-Bakar, Thinesh L Krishnamoorthy, Hang Hock Shim, Kiang Hiong Tay, Wan Cheng Chow. Perceptions of non-alcoholic fatty liver disease – an Asian community-based study. Gastroenterology Report 2016; 4(2): 131 doi: 10.1093/gastro/gov047
|
| 56 |
Shoukat Ali Samejo, Zaigham Abbas, Muhammad Asim. Effects of anthropometric and metabolic parameters on transaminase levels and liver stiffness in patients with non-alcohol fatty liver disease. Tropical Doctor 2021; 51(2): 185 doi: 10.1177/0049475520962742
|
| 57 |
Juan C Lopez-Delgado, Josep Ballus, Francisco Esteve, Nelson L Betancur-Zambrano, Vicente Corral-Velez, Rafael Mañez, Antoni J Betbese, Joan A Roncal, Casimiro Javierre. Outcomes of abdominal surgery in patients with liver cirrhosis. World Journal of Gastroenterology 2016; 22(9): 2657-2667 doi: 10.3748/wjg.v22.i9.2657
|
| 58 |
Youn Huh, Yoon Jeong Cho, Ga Eun Nam. Recent Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease. Journal of Obesity & Metabolic Syndrome 2022; 31(1): 17 doi: 10.7570/jomes22021
|
| 59 |
Chiao-Lin Hsu, Fu-Zong Wu, Kung-Hung Lin, Yu-Hsun Chen, Pin-Chieh Wu, Yan-Hua Chen, Chi-Shen Chen, Wen-Hwa Wang, Guang-Yuan Mar, Hsien-Chung Yu. Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup. Clinical and Translational Gastroenterology 2019; 10(5): e00042 doi: 10.14309/ctg.0000000000000042
|
| 60 |
Letiția Adela Maria Streba, Cristin Constantin Vere, Ion Rogoveanu, Costin Teodor Streba. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: An open question. World Journal of Gastroenterology 2015; 21(14): 4103-4110 doi: 10.3748/wjg.v21.i14.4103
|
| 61 |
Zahra Dehnavi, Farkhonde Razmpour, Mahmoud Belghaisi Naseri, Mohsen Nematy, Seyed Ali Alamdaran, Hassan Ali Vatanparast, Mohsen Azimi Nezhad, Bita Abbasi, Azita Ganji. Fatty Liver Index (FLI) in Predicting Non-alcoholic Fatty Liver Disease (NAFLD). Hepatitis Monthly 2018; 18(2) doi: 10.5812/hepatmon.63227
|
| 62 |
Peter R. Galle, Masatoshi Kudo, Josep M. Llovet, Richard S. Finn, Mark Karwal, Denis Pezet, Tae‐You Kim, Tsai‐Sheng Yang, Sara Lonardi, Jiri Tomasek, Jean‐Marc Phelip, Yann Touchefeu, Su‐Jin Koh, Guido Stirnimann, Kun Liang, Kenyon D. Ogburn, Chunxiao Wang, Paolo Abada, Ryan C. Widau, Andrew X. Zhu. Ramucirumab in patients with previously treated advanced hepatocellular carcinoma: Impact of liver disease aetiology. Liver International 2021; 41(11): 2759 doi: 10.1111/liv.14994
|
| 63 |
Hale Tuhan, Ayhan Abacı, Ahmet Anık, Gönül Çatlı, Tuncay Küme, Özlem Gürsoy Çalan, Sezer Acar, Ece Böber. Circulating betatrophin concentration is negatively correlated with insulin resistance in obese children and adolescents. Diabetes Research and Clinical Practice 2016; 114: 37 doi: 10.1016/j.diabres.2016.02.008
|
| 64 |
Doreen Liou, Jessica A. Karasik. Living Environment Considerations on Obesity Prevention Behaviors and Self-Efficacy among Chinese Americans. International Journal of Environmental Research and Public Health 2021; 18(17): 9322 doi: 10.3390/ijerph18179322
|
| 65 |
Vyacheslav Buko, Ilya Zavodnik, Bartlomiej Palecz, Artur Stepniak, Siarhei Kirko, Alexej Shlyahtun, Wiesława Misiuk, Elena Belonovskaya, Oxana Lukivskaya, Elena Naruta, Irina Kuzmitskaya, Tatsiana Ilyich, Bayarmaa Erdenebayar, Sluken Rakhmadieva. Betulin/2-hydroxypropyl-β-cyclodextrin inclusion complex: Physicochemical characterization and hepatoprotective activity. Journal of Molecular Liquids 2020; 309: 113118 doi: 10.1016/j.molliq.2020.113118
|
| 66 |
Anita Krishnarao, Carmi S. Punzalan. National and Global Ethnicity Differences in Non-alcoholic Fatty Liver Disease. Current Hepatology Reports 2020; 19(4): 429 doi: 10.1007/s11901-020-00552-8
|
| 67 |
|
| 68 |
Deborah Edelman, Harmit Kalia, Maria Delio, Mustafa Alani, Karthik Krishnamurthy, Mortadha Abd, Adam Auton, Tao Wang, Allan W. Wolkoff, Bernice E. Morrow. Genetic analysis of nonalcoholic fatty liver disease within a Caribbean–Hispanic population. Molecular Genetics & Genomic Medicine 2015; 3(6): 558 doi: 10.1002/mgg3.168
|
| 69 |
Channa R. Jayasekera, Mindie H. Nguyen. Cancer Epidemiology Among Asian Americans. 2016; : 233 doi: 10.1007/978-3-319-41118-7_10
|
| 70 |
Martina Chiurazzi, Nunzia Cacciapuoti, Mariastella Di Lauro, Gilda Nasti, Margherita Ceparano, Elisabetta Salomone, Bruna Guida, Maria Serena Lonardo. The Synergic Effect of a Nutraceutical Supplementation Associated to a Mediterranean Hypocaloric Diet in a Population of Overweight/Obese Adults with NAFLD. Nutrients 2022; 14(22): 4750 doi: 10.3390/nu14224750
|
| 71 |
Win Min Han, Tanakorn Apornpong, Pairoj Chattranukulchai, Sarawut Siwamogsatham, Hay Mar Su Lwin, Jedsadakorn Boonrungsirisap, Thanathip Wichiansan, Sivaporn Gatechompol, Sasiwimol Ubolyam, Stephen J. Kerr, Pisit Tangkijvanich, Anchalee Avihingsanon. Metabolic‐Associated Fatty Liver Disease (MAFLD) is associated with immune activation, increased epicardial fat volume, and steatohepatitis among people with HIV in a Thai cohort. HIV Medicine 2023; 24(9): 1000 doi: 10.1111/hiv.13499
|
| 72 |
Aastha Jindal, Anusha Thadi, Kunwar Shailubhai. Hepatocellular Carcinoma: Etiology and Current and Future Drugs. Journal of Clinical and Experimental Hepatology 2019; 9(2): 221 doi: 10.1016/j.jceh.2019.01.004
|
| 73 |
Jie You, Sha Huang, Gui-Qian Huang, Gui-Qi Zhu, Rui-Min Ma, Wen-Yue Liu, Ke-Qing Shi, Gui-Long Guo, Yong-Ping Chen, Martin Braddock, Ming-Hua Zheng. Nonalcoholic Fatty Liver Disease. Medicine 2015; 94(5): e479 doi: 10.1097/MD.0000000000000479
|
| 74 |
Ian James Martins. Non-Alcoholic Fatty Liver Disease - Molecular Bases, Prevention and Treatment. 2018; doi: 10.5772/intechopen.70581
|
| 75 |
Darnna E. Banks, Yael Bogler, Taft Bhuket, Benny Liu, Robert J. Wong. Significant disparities in risks of diabetes mellitus and metabolic syndrome among chronic hepatitis C virus patients in the U.S.. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2017; 11: S153 doi: 10.1016/j.dsx.2016.12.025
|
| 76 |
Firzan Nainu, Andri Frediansyah, Sukamto S. Mamada, Andi Dian Permana, Mirnawati Salampe, Deepak Chandran, Talha Bin Emran, Jesus Simal-Gandara. Natural products targeting inflammation-related metabolic disorders: A comprehensive review. Heliyon 2023; 9(6): e16919 doi: 10.1016/j.heliyon.2023.e16919
|
| 77 |
Anne-Catherine Schwarz, Adrian T. Billeter, Katharina M. Scheurlen, Matthias Blüher, Beat P. Müller-Stich. Comorbidities as an Indication for Metabolic Surgery. Visceral Medicine 2018; 34(5): 381 doi: 10.1159/000493291
|
| 78 |
Haw-Wen Chen, Chih-Ching Yen, Li-Li Kuo, Chia-Wen Lo, Chin-Shiu Huang, Chih-Chieh Chen, Chong-Kuei Lii. Benzyl isothiocyanate ameliorates high-fat/cholesterol/cholic acid diet-induced nonalcoholic steatohepatitis through inhibiting cholesterol crystal-activated NLRP3 inflammasome in Kupffer cells. Toxicology and Applied Pharmacology 2020; 393: 114941 doi: 10.1016/j.taap.2020.114941
|
| 79 |
Safoora Nabavi, Maryam Rafraf, Mohammad-hossein Somi, Aziz Homayouni-Rad, Mohammad Asghari-Jafarabadi. Probiotic yogurt improves body mass index and fasting insulin levels without affecting serum leptin and adiponectin levels in non-alcoholic fatty liver disease (NAFLD). Journal of Functional Foods 2015; 18: 684 doi: 10.1016/j.jff.2015.08.031
|
| 80 |
Thomas Jensen, Amanda Wieland, Melanie Cree-Green, Kristen Nadeau, Shelby Sullivan. Clinical workup of fatty liver for the primary care provider. Postgraduate Medicine 2019; 131(1): 19 doi: 10.1080/00325481.2019.1546532
|
| 81 |
Fatih Battal, Hakan Türkön, Nilüfer Aylanç, Hakan Aylanç, Şule Yıldırım, Nazan Kaymaz, Sema Uysal. Investigation of Blood Betatrophin Levels in Obese Children with Non-Alcoholic Fatty Liver Disease. Pediatric Gastroenterology, Hepatology & Nutrition 2018; 21(2): 111 doi: 10.5223/pghn.2018.21.2.111
|
| 82 |
Luis Aldámiz-Echevarría, Javier de las Heras, María Luz Couce, Carlos Alcalde, Isidro Vitoria, María Bueno, Javier Blasco-Alonso, María Concepción García, Mónica Ruiz, Rafael Suárez, Fernando Andrade, Olatz Villate. Non-alcoholic fatty liver in hereditary fructose intolerance. Clinical Nutrition 2020; 39(2): 455 doi: 10.1016/j.clnu.2019.02.019
|
| 83 |
Samira Faraji, Mohammad Reza Mohammad Hosseini Azar, Mohammad Alizadeh. Brewed chicory leaf consumption has unexpected side effects along beneficial effects on liver enzymes in non-alcoholic fatty liver disease patients. Journal of Herbal Medicine 2022; 34: 100572 doi: 10.1016/j.hermed.2022.100572
|
| 84 |
Umair Iqbal, Brandon Perumpail, Daud Akhtar, Donghee Kim, Aijaz Ahmed. The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease. Medicines 2019; 6(1): 41 doi: 10.3390/medicines6010041
|
| 85 |
Bo Kyung Koo, Won Kim. Reply. Clinical Gastroenterology and Hepatology 2021; 19(2): 413 doi: 10.1016/j.cgh.2020.04.044
|
| 86 |
Aynur Unalp-Arida, Constance E. Ruhl. Transient Elastography–Assessed Hepatic Steatosis and Fibrosis Are Associated With Body Composition in the United States. Clinical Gastroenterology and Hepatology 2022; 20(4): e808 doi: 10.1016/j.cgh.2021.02.009
|
| 87 |
Kuen Cheh Yang, Hui-Fang Hung, Chia-Wen Lu, Hao-Hsiang Chang, Long-Teng Lee, Kuo-Chin Huang. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance. Scientific Reports 2016; 6(1) doi: 10.1038/srep27034
|
| 88 |
Rui-Bing Feng, Chun-Lin Fan, Qing Liu, Zhong Liu, Wei Zhang, Yao-Lan Li, Wei Tang, Ying Wang, Man-Mei Li, Wen-Cai Ye. Crude triterpenoid saponins from Ilex latifolia (Da Ye Dong Qing) ameliorate lipid accumulation by inhibiting SREBP expression via activation of AMPK in a non-alcoholic fatty liver disease model. Chinese Medicine 2015; 10(1) doi: 10.1186/s13020-015-0054-9
|